Clinical Roundup IU study: Vaccine protects most cancer patients from COVID-19, but risk remains higher for patients with blood cancers April 08, 2022Vol.48 No.14
Clinical Roundup Real-world data show potential of Cosela to reduce myelosuppression in ES-SCLC treated with chemo April 08, 2022Vol.48 No.14
Clinical Roundup VCU and UF study: Black patients more likely to be excluded from pancreatic cancer clinical trials April 01, 2022Vol.48 No.13
Clinical Roundup Fox Chase researchers study PTEN mutations in CRC to enhance clinical targeting April 01, 2022Vol.48 No.13
Clinical Roundup Yale researchers identify accelerated genetic aging in breast tissue adjacent to breast cancer tumors April 01, 2022Vol.48 No.13
Clinical Roundup Fox Chase study: Newly defined renal neoplasm has low risk of metastasis April 01, 2022Vol.48 No.13
Clinical Roundup SKYSCRAPER-02, the first randomized study of tiragolumab in ES-SCLC, did not meet co-primary endpoint of PFS, Genentech says April 01, 2022Vol.48 No.13
Clinical Roundup Rubraca improves PFS in first-line maintenance treatment of ovarian cancer regardless of biomarker status in phase III ATHENA-MONO trial April 01, 2022Vol.48 No.13
Clinical Roundup Enrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20% March 25, 2022Vol.48 No.12
Clinical Roundup NCI launches program for molecular characterization of childhood cancers March 25, 2022Vol.48 No.12
